Through Western blot experiments, we detected significantly higher expression levels of TNFSF10 and IL18 in PCOS patients compared to the healthy control group, while the expression level of CASP2 was significantly reduced (Fig 5A, S1A Fig). This evidence concerns the gene CASP2 and polycystic ovary syndrome.